Wnt3a suppresses Pseudomonas aeruginosa-induced inflammation and promotes bacterial killing in macrophages

Kang Chen1, Qiang Fu1, Dandan Li2

  • 1Division of Clinical Laboratory, Zhongshan Hospital of Sun Yat‑Sen University, Zhongshan, Guangdong 528403, P.R. China.

Insights

Wingless-type MMTV integration site family, member 3A (Wnt3a) suppresses Pseudomonas aeruginosa inflammation by reducing pro-inflammatory cytokines and enhancing macrophage apoptosis. Wnt3a also boosts bacterial clearance through antimicrobial peptide production.

Area of Science:

  • Immunology
  • Microbiology
  • Molecular Biology

Background:

  • Pseudomonas aeruginosa (PA) causes severe infections linked to inflammation and virulence factors.
  • The role of Wingless-type MMTV integration site family, member 3A (Wnt3a) in PA infection is unknown.
  • Wnt3a is an upstream mediator in the Wnt signaling pathway, known to regulate inflammation.

Purpose of the Study:

  • To investigate the role of Wnt3a in Pseudomonas aeruginosa-induced inflammation.
  • To determine Wnt3a's effect on macrophage apoptosis and bacterial clearance.
  • To elucidate the mechanisms underlying Wnt3a's function in host resistance to PA.

Main Methods:

  • Western blotting and immunofluorescence to assess Wnt3a pathway activation (β-catenin).
  • Reverse transcription-quantitative polymerase chain reaction to measure pro-inflammatory cytokine mRNA levels.
  • Flow cytometry to evaluate macrophage apoptosis and intracellular bacterial killing.

Main Results:

  • Wnt3a upregulates β-catenin, indicating activation of the Wnt signaling pathway.
  • Wnt3a suppresses PA-induced inflammation by reducing pro-inflammatory cytokine production.
  • Wnt3a promotes macrophage apoptosis and enhances intracellular bacterial killing via antimicrobial peptide induction.

Conclusions:

  • Wnt3a plays a protective role in Pseudomonas aeruginosa infections.
  • Wnt3a modulates host immune responses, including inflammation and bacterial clearance.
  • Wnt3a may represent a therapeutic target for improving host resistance to PA infections.